Study to Evaluate the Efficacy and Safety of Roxadustat in the Treatment of Anemia in Participants With ESRD on Stable Dialysis

NCT02273726 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

741

Enrollment

INDUSTRY

Sponsor class

Conditions

CKD Anemia in Stable Dialysis Patients

Interventions

DRUG: Epoetin Alfa
DRUG: Roxadustat

Sponsor

Kyntra Bio

Collaborators

[object Object]
[object Object]